Page last updated: 2024-08-22

camptothecin and Vascular Diseases

camptothecin has been researched along with Vascular Diseases in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Di Bartolo, BA; Kavurma, MM; Mattar, MZ; Rachner, TD; Schoppet, M; Shanahan, CM1
Meropol, NJ; Poplin, EA; Rothenberg, ML; Van Cutsem, E; Wadler, S1

Other Studies

2 other study(ies) available for camptothecin and Vascular Diseases

ArticleYear
Calcium and osteoprotegerin regulate IGF1R expression to inhibit vascular calcification.
    Cardiovascular research, 2011, Aug-01, Volume: 91, Issue:3

    Topics: Animals; Apoptosis; Calcinosis; Calcium; Camptothecin; Cells, Cultured; Feedback, Physiological; Gene Expression Regulation; Humans; Muscle, Smooth, Vascular; Mutation; Myocytes, Smooth Muscle; NF-kappa B; Osteoprotegerin; Proto-Oncogene Proteins c-bcl-2; Rats; Receptor, IGF Type 1; RNA Interference; RNA, Messenger; Sp1 Transcription Factor; Time Factors; Transfection; Vascular Diseases

2011
Mortality associated with irinotecan plus bolus fluorouracil/leucovorin: summary findings of an independent panel.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2001, Sep-15, Volume: 19, Issue:18

    Topics: Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cause of Death; Fluorouracil; Gastrointestinal Diseases; Guidelines as Topic; Irinotecan; Leucovorin; Mortality; Randomized Controlled Trials as Topic; Risk Factors; Syndrome; Time Factors; Vascular Diseases

2001